杭州桐庐尖端内窥镜有限公司是集开发、研制、生产和销售医用内窥镜及手术器械为一体的省高新技术企业，是"浙江省100个拳头产品骨干企业"、"浙江省工商信用AAA级'守合同、重信用'单位"。公司生产的内窥镜是浙江省名牌产品，"天松"牌商标是浙江省著名商标。

　　公司现有员工210人，注册资金3000万元，2003年实现销售收入近亿元。公司的胸腔镜被认定为2004年度国家重点新产品。公司通过ISO9001及YY/T0287国际质量体系认证和欧共体CE认证，目前公司拥有国家专利14项，在研发能力、技术水平、生产能力和经营规模均居同行业之首，公司26个系列产品覆盖全国，并远销德、美、日、韩等二十多个国家和地区。

　　公司下一步希望通过"以民引外，民外合璧"的模式，引进国外先进的管理模式和先进技术、拓展更广阔的国内外市场空间，将与全球内窥镜行业巨头德国WOLF公司合资合作，强强联合，做亚洲最大的内窥镜生产基地！

　　Title of the enterprise: Hangzhou Tonglu Frontier Endoscope Co., Ltd.

　　Industry: Medicine

　　Legal representative: Xu Tiansong

　　Add: Zhejiang Tonglu Economic and Technical Development Zone

　　Contact person: Cai Ligang Tel. 86-571-64241288

　　Fax： 86-571-64241918

　　A brief introduction to the enterprise

　　Hangzhou Tonglu Frontier Endoscope Co., Ltd. Is a high-tech enterprise at the provincial level which integrates R&D of medical endoscope and surgical machinery with production and sales. It is also listed among "100 Zhejiang core enterprises with competitive products" as well as "Zhejiang 'contract honoring and credit respecting' enterprises with Credit Rating AAA ". The endoscope produced by the company is a brand-name product in Zhejiang and " Tiansong" is a provincial renowned brand.

　　The company boasts 210 staff members with a registered capital of 30 million yuan. It registered nearly 100 million yuan in sales revenue in 2003. The thoracoscope produced by the company has been listed among state key new products in 2004. It has passed the certification of International Quality System ISO 9001 and YY/T0287 as well as the certification of CE in European Community. At present the company has acquired 14 state patents and ranks first among the companies in the same industry in terms of R&D capability, technical level, production capability and business scale. The 26 series products of the company have found way into the markets nationwide and have been exported to more than 20 countries and regions such as Germany, the US, Japan Korea and so on.

　　The company plans to introduce advanced foreign management modes and techniques to explode wider overseas markets by adopting the development mode of inviting foreign investment through private capital and combining private capital with foreign investment. It intends to open up joint ventures and cooperate with a German company, WOLF, which is a tycoon in global endoscope industry with two strong companies, WOLF and itself, making joint efforts to build the largest production base of endoscope in Asia